CN Patent

CN104031122B — 有关Cyclin D蛋白抑制剂多肽及其应用

Assigned to Changzhou Cancer Hospital · Expires 2016-05-11 · 10y expired

What this patent protects

本发明涉及药物领域，具体涉及具有抑制Cyclin？D蛋白表达，治疗套细胞淋巴瘤的多肽。其序列为SVSYFKCVQKEVLPSMRKIV是全新的序列，该多肽可体外抑制套细胞淋巴瘤细胞G519和z138细胞增殖和迁移，治疗套细胞淋巴瘤，具有潜在的新药开发价值。

USPTO Abstract

本发明涉及药物领域，具体涉及具有抑制Cyclin？D蛋白表达，治疗套细胞淋巴瘤的多肽。其序列为SVSYFKCVQKEVLPSMRKIV是全新的序列，该多肽可体外抑制套细胞淋巴瘤细胞G519和z138细胞增殖和迁移，治疗套细胞淋巴瘤，具有潜在的新药开发价值。

Drugs covered by this patent

Patent Metadata

Patent number
CN104031122B
Jurisdiction
CN
Classification
—
Expires
2016-05-11
Drug substance claim
No
Drug product claim
No
Assignee
Changzhou Cancer Hospital
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.